Acquisition Completed
Fulgent Genetics acquisition of Bako Diagnostics selected assets
US$56.9m consideration
Announced 22 Dec 2025
Advisers
Bako Diagnostics selected assets
Target
- Financial adviser
- EV Health Partners
- Legal adviser
- Target
- Bako Diagnostics selected assets
- Acquirer
- Fulgent Genetics
- Target based in
- United States (unverified)
- Buyer based in
- United States
- Completed
- 17 Mar 2026
- Sector
- Diagnostics
- Tags
- Diagnostics, Healthcare Services
In the league tables
Similar deals
- Labcorp acquisition of Select assets of BioReference Health Oct 2026 · Diagnostics
- Tamarind Health acquisition of Hong Kong Women’s Imaging, Hong Kong MRI and Hong Kong Medical Imaging group May 2026 · Healthcare Services
- ImaOne acquisition of MediGroup 2026 · Diagnostics
- Timothy R. Damadian acquisition of FONAR Dec 2025 · Medtech
- Australian Unity acquisition of Plena Healthcare Jul 2025 · US$45.9m · Healthcare Services
